高速分拣大细胞的泵
|
By LabMedica International staff writers Posted on 25 Aug 2017 |

图片:微流控芯片能够以16微秒的高速分拣细胞。放大视图展示了片上分拣小眼虫细胞(图片蒙名古屋大学惠赐)。
许多医疗应用场合必须分拣单个细胞,包括从细胞悬液中分离特定的细胞类型。科研人员已经用荧光活化细胞分拣(FACS)做高通量细胞分拣。
较大细胞的FACS要求在低压下处理样本,让样本通过更宽的喷嘴,以防止损坏,因此分拣受限于低水平通量。用激光激励液滴中细胞的自体荧光或标记荧光,然后使液滴发生偏转,按照不同特性进入不同容器。因为产生的喷雾剂导致样本感染,所以这项技术引人担忧。
日本名古屋大学的科学家研究细胞分拣时用一颗微流控芯片预防样本感染。这颗芯片有微通道,将细胞悬液导入微通道进行分拣。科研小组在微流控芯片里集成了两只外部驱动的片上泵,以实现高速的流控制。他们用一只高速发动器作为泵的动力源,成功生成了一股持续16微秒的液流,进行细胞分拣。
虽然提出了各种片上细胞分拣方法,但是大细胞的高通量分拣仍受制于在大范围分拣区内控制高速液流的困难。为克服这一难题,科研小组提出把压电发动器放在微流控芯片外,用它驱动双膜泵,实现高速的局部流控制。他们评估了把液流特征换成局部流的可控性。
他们用这项技术不仅能分拣大细胞,还能分拣小细胞,而且速度快,纯度高,活力强。以100微米左右的微藻类为例测试该方法,得到95.8%的纯度、90.8%的存活率和92.8%的成功率。他们用24微米左右的癌细胞作为小细胞的模型,得到了98.9%的纯度、90.7%的存活率和97.8%的成功率。
该研究的论文发表于2017年6月14日的《芯片实验室》杂志。领衔作者、助理教授Shinya Sakuma博士说:“微流控芯片拥有十字形分拣区和有三个分支的微流控通道。主通道里的靶体/非靶体细胞在三个维度上对齐。当检测到靶细胞时,片上泵迅速启动,把细胞拣入两条兴趣通道之一。同时,把非靶细胞冲入废料通道,泵不发动。
Related Links:
名古屋大学
较大细胞的FACS要求在低压下处理样本,让样本通过更宽的喷嘴,以防止损坏,因此分拣受限于低水平通量。用激光激励液滴中细胞的自体荧光或标记荧光,然后使液滴发生偏转,按照不同特性进入不同容器。因为产生的喷雾剂导致样本感染,所以这项技术引人担忧。
日本名古屋大学的科学家研究细胞分拣时用一颗微流控芯片预防样本感染。这颗芯片有微通道,将细胞悬液导入微通道进行分拣。科研小组在微流控芯片里集成了两只外部驱动的片上泵,以实现高速的流控制。他们用一只高速发动器作为泵的动力源,成功生成了一股持续16微秒的液流,进行细胞分拣。
虽然提出了各种片上细胞分拣方法,但是大细胞的高通量分拣仍受制于在大范围分拣区内控制高速液流的困难。为克服这一难题,科研小组提出把压电发动器放在微流控芯片外,用它驱动双膜泵,实现高速的局部流控制。他们评估了把液流特征换成局部流的可控性。
他们用这项技术不仅能分拣大细胞,还能分拣小细胞,而且速度快,纯度高,活力强。以100微米左右的微藻类为例测试该方法,得到95.8%的纯度、90.8%的存活率和92.8%的成功率。他们用24微米左右的癌细胞作为小细胞的模型,得到了98.9%的纯度、90.7%的存活率和97.8%的成功率。
该研究的论文发表于2017年6月14日的《芯片实验室》杂志。领衔作者、助理教授Shinya Sakuma博士说:“微流控芯片拥有十字形分拣区和有三个分支的微流控通道。主通道里的靶体/非靶体细胞在三个维度上对齐。当检测到靶细胞时,片上泵迅速启动,把细胞拣入两条兴趣通道之一。同时,把非靶细胞冲入废料通道,泵不发动。
Related Links:
名古屋大学
Latest 实验室技术 News
Channels
Clinical Chemistry
view channelNext Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read more
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read moreMolecular Diagnostics
view channel
Immune Signatures in Blood Help Inform Cancer Risk in Lynch Syndrome
Lynch syndrome is a hereditary condition that increases risk for colorectal and endometrial cancers and often results in earlier-onset disease. Clinicians need better ways to stratify asymptomatic carriers... Read more
Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is a progressive condition characterized by obstructed pulmonary blood flow and strain on the right heart, with half of patients dying within five years of diagnosis.... Read more
Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers
Racial survival disparities in early-stage breast cancer remain a persistent clinical concern in the United States, with Black women experiencing higher mortality despite similar treatments.... Read more
cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read moreHematology
view channel
Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
Blood cancers encompass diverse entities whose biology and clinical behavior are best understood through integrative analyses across large cohorts. However, multi‑omic datasets and outcomes information... Read more
AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
Bone marrow aspirate examination is central to diagnosing and monitoring blood cancers and other serious hematologic diseases, yet the process in many laboratories remains manual and highly dependent on... Read moreImmunology
view channelCombined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read more
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read morePathology
view channel
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer mortality worldwide, with China bearing nearly half of the global burden. Only a subset of patients benefit from... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channelGlobal Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more







